InvestorsHub Logo
Followers 30
Posts 5099
Boards Moderated 0
Alias Born 01/07/2020

Re: couldbebetter post# 301767

Sunday, 09/27/2020 1:36:08 PM

Sunday, September 27, 2020 1:36:08 PM

Post# of 429456
cbb@ I'm no expert in Bio deals - but just an example of a teoretic possible scenario from the sideline.
---------------------------

Lets say Teva - bought 40% of Amarin today - with the option to buy rest of company in say 2- 3 years - at a price fair to both measured from preset facts earnings/outlook at a given future date.

Teva have the logistics and sales organisation to make Vascepa - BIG FAST.

This would give Amarin a chance to recover from patent loss (SP going North) - and Teva the time to 'test the true potential of this CDV savier drug - in timely manner replacing Lovaza.
----------------------------------------

I always see you arguing for BO - which is fair enough.

Would a deal like - the one lined out above (or something along that line) be acceptable for you ?

Jasbg

PS. I have been talking Teva a number of times - and therefore have to stress' that I only know Teva from internet - as a layperson. Only reason I would find a cooperation/partnership interesting - is the fact that Teva was the first to make a generic settlement (indicates they know Amarin)

And from outside - the same AG Vascepa product Worldwide - would seem to be easier both in production - logistics and marketing to make Big' in sales Fast'.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News